eHealth Raises 2025 Revenue and Profit Guidance After Strong AEP Performance

Reuters12-18
eHealth Raises 2025 Revenue and Profit Guidance After Strong AEP Performance

eHealth Inc. has updated its financial guidance for the fiscal year ending December 31, 2025, reflecting improved business performance following a strong Annual Enrollment Period. The company now expects total revenue to be in the range of $540 million to $560 million, up from the previous outlook of $525 million to $565 million. GAAP net income (loss) guidance has been raised significantly to a range of $30 million to $45 million, compared to the prior range of $9 million to $30 million. Adjusted EBITDA is now anticipated to be between $80 million and $95 million, higher than the earlier forecast of $60 million to $80 million. Operating cash flow is projected to be in the range of $(25.0) million to $0 million, slightly narrowed from the previous range of $(25.0) million to $10.0 million. The updated guidance also includes positive net adjustment revenue expected in the range of $40 million to $45 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. eHealth Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF50467) on December 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment